Supplementary File 4 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer

Supplementary File 4 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer

<p>Excel file with regulon edges and ChIP-seq enrichment scores for TraRe, GRNboost2 and ARACNE-AP</p>

Furkejuvvon:

Bibliográfalaš dieđut
Váldodahkki:	Charles Blatti (15292859) (author)
Eará dahkkit:	Jesús de la Fuente (15292862) (author), Huanyao Gao (14962434) (author), Irene Marín-Goñi (15292865) (author), Zikun Chen (15292868) (author), Sihai D. Zhao (15292871) (author), Winston Tan (15035292) (author), Richard Weinshilboum (15292874) (author), Krishna R. Kalari (15099627) (author), Liewei Wang (14962464) (author), Mikel Hernaez (15292877) (author)
Almmustuhtton:	2025
Fáttát:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Computational Methods Artificial intelligence & machine learning Drug Resistance Novel mechanisms Regulation of gene expression in drug resistance Gene Regulation Genitourinary Cancers Prostate cancer Systems Biology
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid

Supplementary File 2 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer
Dahkki: Charles Blatti (15292859)
Almmustuhtton: (2025)

Supplementary File 3 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer
Dahkki: Charles Blatti (15292859)
Almmustuhtton: (2025)

Supplementary Table S1 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Dahkki: Yufang Bao (15386826)
Almmustuhtton: (2025)

Supplementary Table S2 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Dahkki: Yufang Bao (15386826)
Almmustuhtton: (2025)

Supplementary Table S3 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Dahkki: Yufang Bao (15386826)
Almmustuhtton: (2025)

Supplementary Table S4 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Dahkki: Yufang Bao (15386826)
Almmustuhtton: (2025)

Supplementary Table S5 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Dahkki: Yufang Bao (15386826)
Almmustuhtton: (2025)

Data file S1 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
Dahkki: Alex C.H. Liu (14961921)
Almmustuhtton: (2025)

Data file S2 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
Dahkki: Alex C.H. Liu (14961921)
Almmustuhtton: (2025)

Data file S3 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
Dahkki: Alex C.H. Liu (14961921)
Almmustuhtton: (2025)

Data file S4 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
Dahkki: Alex C.H. Liu (14961921)
Almmustuhtton: (2025)

Data file S5 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
Dahkki: Alex C.H. Liu (14961921)
Almmustuhtton: (2025)

Table S1 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
Dahkki: Alex C.H. Liu (14961921)
Almmustuhtton: (2025)

Supplementary Data from <i>N</i><sup>6</sup>-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer
Dahkki: Jiachun Su (16990970)
Almmustuhtton: (2025)

Figure S1 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Dahkki: Shiyi Yu (17079079)
Almmustuhtton: (2025)

Figure S2 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Dahkki: Shiyi Yu (17079079)
Almmustuhtton: (2025)

Figure S3 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Dahkki: Shiyi Yu (17079079)
Almmustuhtton: (2025)

Figure S4 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Dahkki: Shiyi Yu (17079079)
Almmustuhtton: (2025)

Figure S5 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Dahkki: Shiyi Yu (17079079)
Almmustuhtton: (2025)

Figure S6 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Dahkki: Shiyi Yu (17079079)
Almmustuhtton: (2025)

Figure S7 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Dahkki: Shiyi Yu (17079079)
Almmustuhtton: (2025)

Figure S8 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Dahkki: Shiyi Yu (17079079)
Almmustuhtton: (2025)

Supplementary Appendix S1 from DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
Dahkki: Bouchra Tawk (15389486)
Almmustuhtton: (2025)

Supplementary Table from CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization
Dahkki: Xiaohong Hong (22681698)
Almmustuhtton: (2025)

Figure 1 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Dahkki: David Milewski (15050643)
Almmustuhtton: (2025)

Figure 2 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Dahkki: David Milewski (15050643)
Almmustuhtton: (2025)

Figure 3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Dahkki: David Milewski (15050643)
Almmustuhtton: (2025)

Figure 4 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Dahkki: David Milewski (15050643)
Almmustuhtton: (2025)

Figure 5 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Dahkki: David Milewski (15050643)
Almmustuhtton: (2025)

Figure 6 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Dahkki: David Milewski (15050643)
Almmustuhtton: (2025)

Supplementary Table S1-S3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Dahkki: David Milewski (15050643)
Almmustuhtton: (2025)

الذكاء الاصطناعي في المصارف الإسلامية: الضوابط والمعايير الشرعية
Dahkki: Al-amrkani, Wijdan Jubran Yousef
Almmustuhtton: (2023)

Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer
Dahkki: Min Wei (16918572)
Almmustuhtton: (2025)

Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer
Dahkki: Min Wei (16918572)
Almmustuhtton: (2025)

Supplemental Figure S1 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Dahkki: Jennifer L. Cotton (17315204)
Almmustuhtton: (2025)

Supplemental Figure S2 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Dahkki: Jennifer L. Cotton (17315204)
Almmustuhtton: (2025)

Supplemental Figure S3 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Dahkki: Jennifer L. Cotton (17315204)
Almmustuhtton: (2025)

Supplemental Figure S4 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Dahkki: Jennifer L. Cotton (17315204)
Almmustuhtton: (2025)

Supplemental Figure S5 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Dahkki: Jennifer L. Cotton (17315204)
Almmustuhtton: (2025)

Supplemental Figure S6 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Dahkki: Jennifer L. Cotton (17315204)
Almmustuhtton: (2025)

Cannot write session to /tmp/vufind_sessions/sess_osuf9ff8g3vt3sui16f6notejl